Skip to main content
Genetic Technologies Limited (GENE)
NASDAQ: GENE · Real-Time Price · USD
0.765
0.00 (0.00%)
Nov 14, 2024, 4:00 PM EST - Market closed

Genetic Technologies Revenue

In the fiscal year ending June 30, 2024, Genetic Technologies had annual revenue of 9.67M AUD, down -6.52%. Genetic Technologies had revenue of 4.80M in the half year ending June 30, 2024, a decrease of -16.72%.

Revenue (ttm)
9.67M AUD
Revenue Growth
-6.52%
P/S Ratio
n/a
Revenue / Employee
175,869 AUD
Employees
55
Market Cap
3.78M USD

Revenue Chart

* This company reports financials in AUD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 20249.67M-675.11K-6.52%
Jun 30, 202310.35M1.13M12.25%
Jun 30, 20229.22M7.88M590.65%
Jun 30, 20211.33M496.87K59.30%
Jun 30, 2020837.87K812.42K3,192.98%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

GENE News

More News